The Lancet14m
Pathogens don't respect politicians: US federal disruption poses a new threat to global public health
We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...
The Lancet16m
A health emergency: Afghanistan's nursing and midwifery ban
Afghanistan's de facto authorities have made the alarming decision to ban women from studying nursing and midwifery.1 This policy, along with the broader ban on girls completing education beyond grade ...
The Lancet1d
Trends in thyroid cancer incidence and overdiagnosis in the USA
In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...
The Lancet2d
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...
The Lancet1d
First phase 3 trial of GLP-1 receptor agonist for neurodegeneration
The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...
The Lancet10d
US exit from WHO: it is about much more than WHO
The announcement by US President Donald Trump that the USA will withdraw from WHO1 will leave both a large financial gap and ...
The Lancet3d
AI for mammography: making double screen-reading history
Artificial intelligence (AI) for mammography is an early exemplar of the integration of AI systems into clinical pathways and ...
The Lancet3d
Applying the estimand framework to inflammatory bowel disease clinical trials
Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...
The Lancet6d
Chronic obstructive pulmonary disease: new therapies and old needs
Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...
The Lancet7d
Rising mpox trends in DR Congo: the neglected spread of an epidemic
The monkeypox virus is causing concurrent outbreaks of mpox in Africa, with more and more frequent exportations outside the ...
The Lancet7d
Hughes Stovin syndrome is not associated with pulmonary embolism – Authors' reply
We would like to thank Nikolas Ruffer and Martin Krusche for their considered Correspondence; their letter raised an important point regarding the nomenclature used in our case report. The authors ...
The Lancet3d
Early antiviral therapy in adults with moderate to highly viraemic chronic hepatitis B
Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...